@article{60cb8ac42f244a65b44dd69fb51816ef,
title = "Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances",
keywords = "LDL cholesterol, PCSK9 inhibitors, RNA-based therapy, atherosclerotic disease, lipid lowering agents",
author = "Dan Atar and Gisle Langslet and Serena Tonstad",
note = "Publisher Copyright: {\textcopyright} 2022 Medycyna Praktyczna Cholerzyn. All rights reserved.",
year = "2022",
doi = "10.33963/KP.a2022.0117",
language = "English",
volume = "80",
pages = "741--749",
journal = "Kardiologia Polska",
issn = "0022-9032",
number = "7-8",
}